531 reports of this reaction
2.0% of all VALSARTAN AND HYDROCHLOROTHIAZIDE reports
#11 most reported adverse reaction
PAIN is the #11 most commonly reported adverse reaction for VALSARTAN AND HYDROCHLOROTHIAZIDE, manufactured by Novartis Pharmaceuticals Corporation. There are 531 FDA adverse event reports linking VALSARTAN AND HYDROCHLOROTHIAZIDE to PAIN. This represents approximately 2.0% of all 26,234 adverse event reports for this drug.
Patients taking VALSARTAN AND HYDROCHLOROTHIAZIDE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for VALSARTAN AND HYDROCHLOROTHIAZIDE, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for VALSARTAN AND HYDROCHLOROTHIAZIDE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 531 FDA reports for VALSARTAN AND HYDROCHLOROTHIAZIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.0% of all adverse event reports for VALSARTAN AND HYDROCHLOROTHIAZIDE, making it a notable side effect.
If you experience pain while taking VALSARTAN AND HYDROCHLOROTHIAZIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.